Physician profile
Victoria L Everton
NPI 1952339038
$2,037.40
in general payments reported to CMS, 2019-2025
20 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Undersea and Hyperbaric Medicine (Emergency Medicine) provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $162 · 2021: $167 · 2022: $220 · 2023: $410 · 2024: $193 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $481.89 | 2019-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Paratek Pharmaceuticals, INC. | $274.71 | 2019-2025 | Nuzyra |
| Kci USA, INC. | $184.95 | 2019-2023 | Activ.A.C., V.A.C. Dermatac, Kerramax Care |
| Organogenesis INC. | $153.71 | 2019-2024 | Puraply Am, Puraply |
| Integra Lifesciences Corporation | $150.52 | 2019-2024 | Tcc-Ez |
| Tei Medical INC. | $126.42 | 2019 | |
| Abbvie INC. | $119.73 | 2021-2023 | |
| Next Science LLC | $108.78 | 2022-2024 | Xperience, Surgx, Blastx |
| Tactile Systems Technology INC | $100.12 | 2019-2023 | Entre Plus, Flexitouch Plus |
| Kerecis Limited | $96.68 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Allergan, INC. | $51.85 | 2019-2020 | |
| Biowound Solutions, INC. | $32.66 | 2025 | Bio-Connekt |
| Melinta Therapeutics, LLC | $31.48 | 2019 | |
| Molnlycke Health Care US, LLC | $24.07 | 2020 | |
| Convatec INC. | $21.45 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Krystal Biotech INC | $19.16 | 2025 | Vyjuvek |
| Nabriva Therapeutics, Plc | $17.09 | 2022 | |
| Medela LLC | $16.31 | 2023 | Invia Motion Endure |
| Solventum Corporation | $14.54 | 2024 | Kerramax Care |
| Merck Sharp & Dohme LLC | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Everton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.